Patent Certifications. ▇▇▇▇▇▇▇▇▇ and DFCI shall notify and provide COMPANY with copies of any allegations of alleged patent invalidity, unenforceability or non-infringement of any PATENT RIGHT pursuant to a Paragraph IV Patent Certification by a Third party filing an Abbreviated New Drug Application, an application under §505(b)(2) or any other similar patent certification by a third party, and any foreign equivalent thereof. Such notification and copies shall be provided to COMPANY within [**] business days after ▇▇▇▇▇▇▇▇▇ and/or DFCI receive such certification.
Appears in 3 contracts
Sources: License Agreement, License Agreement (Syros Pharmaceuticals, Inc.), License Agreement (Syros Pharmaceuticals, Inc.)
Patent Certifications. ▇▇▇▇▇▇▇▇▇ and DFCI shall notify and provide COMPANY with copies of any allegations of alleged patent invalidity, unenforceability or non-infringement of any PATENT RIGHT pursuant to a Paragraph IV Patent Certification by a Third party filing an Abbreviated New Drug Application, an application under §505(b)(2) or any other similar patent certification by a third party, and any foreign equivalent thereof. Such notification and copies shall be provided to COMPANY within [**] business days after ▇▇▇▇▇▇▇▇▇ and/or DFCI receive receives such certification.
Appears in 2 contracts
Sources: License Agreement (Syros Pharmaceuticals, Inc.), License Agreement (Syros Pharmaceuticals, Inc.)